Health on the menu at Nature’s Goodness in Welland

Who has spent three years preparing to head out on her own after a career working in the health food industry.


Health-conscious individuals may want to take a trip down West Main Street.

Nature’s Goodness Health Foods and Wellness opened this week at 98 West Main St., kicking off seven days of prize giveaway running until Saturday as part of the store’s grand opening. Establishing a shop of her own — specializing in a full range of vitamins, supplements, essential oils, organic foods and more — has long been the dream of owner Sarina Giansante, who has spent three years preparing to head out on her own after a career working in the health food industry.


“I thought I would finally give it a shot,” said Giansante, who is paring the products offered on her shelves, ranging from organic and natural beauty and bath products to dietary supplements, with in-house organic tea and coffee products. She has set up a seating area, replete with Himalayan salts to provide guests a relaxing environment to enjoy their beverages, such as organic cappuccinos, and as she moves forward, organic food offerings.

The field is a passion for the certified biofeedback technician, who aims to find natural remedies for ailments that might otherwise require medication.

The Latest Medical Technology In The NHS – Including [Blockchain And AI]

NHS £8.5 million by reducing the cost of treatment required and £138 million over five years thanks to reduced hospital admissions.

Not a day goes by without another headline bemoaning the lack of finance and resources that the NHS currently suffers from, but in a far corner of London a new accelerator scheme is trying to address that.

Incubating over 20 companies, the NHS has put together a Digital Health.London Accelerator to fast-track tools and software that could potentially help patients or supply savings to the already stretched public health service.

Adopting these innovations could be a way for the government to reduce spending on certain running costs, allowing for more investment in other areas of the service or to cut the deficit faced by the NHS on an annual basis.

And of course, there are other private studies already in operation in other parts of the NHS.

Here is a sneak peak of some of the tech-focused companies the scheme is currently working with:

Dr. Julian Medical Group Ltd aims to increase accessibility to mental health services, thus reducing waiting times. Patients with mental health problems have been proven to deteriorate if left untreated leading to higher cost. Individual sessions are more affordable too and could lead to savings of £29 million if 10% of treatments were undertaken via the platform.



Dr. Toolbox Ltd is an information service allowing for staff who are working in a different facility than they were trained in to access any necessary knowledge about the inner workings of the establishment. Developers estimate that the tool saves doctors an average of 40 minutes per day and could save the average hospital £200,000 per year.

Locum’s Nest is a platform that connects locum staff to temporary roles within NHS organizations. It is the first collaborative digital staff bank and has fill-rates of over 90% trust-wide resulting in cost savings of over £2.5 million each year.

Synopsis Healthcare provides a streamlined preoperative process using online assessment questionnaires. The screening aims to reduce the number of procedures canceled on the day. It is estimated that £65 million could be saved through the streamlining of the process, with 40% of low-risk patients no longer needing to attend an in-person preoperative appointment.


Healum Ltd allows patients to monitor their chronic physical or mental health condition in a cost-effective way. For example, with the help of the app, 150,000 patients have reduced their level of HBA1c by 1% or more. It is estimated this type of access to monitoring could save the NHS £8.5 million by reducing the cost of treatment required and £138 million over five years thanks to reduced hospital admissions.

Trakka Medical (HaMpton) uses an app to allow patients to monitor their blood pressure at home. The app alerts patients if they need to attend the hospital and also can be monitored by clinicians remotely. Use of the app resulted in a 53% reduction in the need for hypertension monitoring appointments and could save the NHS £50 million annually if scaled up across the country.

Trayned Insight Ltd analyses hundreds of performance and outcome measures in primary care which can be used to improve patient care, the effectiveness of treatment and cost efficiency. Use of the technology could save the NHS £700 million in drug prescriptions annually and would reduce the number of urgent care admissions by nearly 40,000 occurrences.

GP and Expert services

DXC Open Health Connect Platform Globally to Create a Connected Ecosystem for Better Healthcare Outcomes

“By 2019, more than 50 percent of life-science and healthcare companies will have dedicated resources to support accessing, sharing and analyzing real-world evidence for use across their organizations.”

DXC Technology , the world’s leading independent, end-to-end IT services company, announced DXC Open Health Connect, a digital health platform that enables healthcare providers to give better quality of care and patient outcomes by enabling interoperability between disparate environments to provide data when and where it’s needed across the healthcare system.

Rising costs, increased regulations and shifting consumer expectations are leading healthcare organizations to seek efficiencies through digital transformation. According to the IDC FutureScape: Worldwide Healthcare 2018 Predictions, “By 2019, more than 50 percent of life-science and healthcare companies will have dedicated resources to support accessing, sharing and analyzing real-world evidence for use across their organizations.”

A connected healthcare ecosystem — including integrated delivery networks, accurate patient data and increased access to information — is essential to lowering costs, improving care quality and boosting patient outcomes. DXC’s agile, cloud-based DXC Open Health Connect enterprise platform delivers the necessary tools and blueprints to healthcare providers and payers to quickly and securely integrate and flow data across the healthcare network.

“As the healthcare industry moves away from a volume-based model in favor of outcomes-based programs, interoperability and data sharing — financial, clinical and operational — will be key to achieving enhanced patient care,” said Andrea Fiumicelli, vice president and general manager, Healthcare and Life Sciences, DXC Technology.

“The future of connected healthcare will be about collaboration and care within and beyond the walls of a hospital or clinic. DXC Open Health Connect encapsulates the future of healthcare by delivering the speed, scale, flexibility and continuous innovation necessary for clients to turn their traditional healthcare systems into major digital-health enablers.”

DXC co-created DXC Open Health Connect with a large academic and research hospital system in metropolitan New York. The solution went into production in 2017, enabling better access to all of the data and technology across the network to discover new insights that are helping to enhance patient engagement, improve operational efficiencies and boost flexibility. Ultimately, DXC Open Health Connect is enabling a shift in focus away from acute care only to concentrating more on promoting lifelong wellness.

For reference click here to continue

Philip Morris International’s smoke-free dream [succeed] in South East Asia?

The new versions aim to further encourage a growing number of smokers to switch as PMI claims Iqos has helped almost six million adult smokers quit cigarettes, with more than half of those in Japan.

As Philip Morris International (PMI) continues on its mission to provide better choices to people who smoke, it faces a major roadblock in Asia Pacific countries that have banned electronic cigarettes (e-cigarettes).

While South Korea and Japan are its biggest markets for e-cigarettes in APAC, governments in South East Asian countries like Singapore, Thailand, Hong Kong have banned the use of these handheld electronic devices, with Malaysia looking to go down the same path.

Despite these restrictions, PMI remains hopeful that its e-cigarettes project, named Iqos, a branded smoke-free heated tobacco unit, will succeed and help the company stop selling cigarettes altogether.

At a global press conference today (23 Oct) in Tokyo, PMI launched the new Iqos 3 and Iqos 3 multi, which it claims integrate consumer insights and feedback it has received to improve design and user experience while maintaining signature taste, sensory attributes and ritual of smoking cigarettes.

The new versions aim to further encourage a growing number of smokers to switch as PMI claims Iqos has helped almost six million adult smokers quit cigarettes, with more than half of those in Japan.

“Our dream was to create a better alternative for smokers, and Iqos has made this dream a reality; it’s a revolution for the 1.1 billion people who smoke,” said André Calantzopoulos, PMI’s chief executive officer at the event.

“Iqos 3 and Iqos 3 multi deliver significant improvement and innovation and mark another step toward convincing all men and women who would otherwise continue to smoke to switch to smoke-free alternatives. Iqos consumers know that this product changes many things in their lives — we thank them, and we thank Japan for leading this positive change.”

However, with this alternative not available to people in the aforementioned SEA countries, Calantzopoulos suggested that the government of these countries that banned e-cigarettes still struggle with the question of whether they should allow better alternatives to cigarettes in the market.

He added that governments have a responsibility to evaluate whether better alternatives should exist, assess the new product and thoroughly examine its benefits, and treat their citizens as adults and give them the information and access to the product.

“I think we have to be very logical here because if a better product exists for consumers, the question is, why these consumers should not have access to this product and information?” he asked, in response to The Drum’s question during the Q&A on whether PSI is still keen to stop selling cigarettes in these SEA countries.

“If this product is not available, what alternatives do people have than continuing to smoke cigarettes? Yes, we can dream of a world where suddenly everyone quits smoking. But for people who are concern about their health, what should we do?”

Calantzopoulos also pointed out that in many other product categories, companies are introducing alternatives. He gave an example of solar panels, which might not have no zero effects on the environment, but is still better than burning coal.

“None of this product has zero effect. Sometimes the discussions that people in public health have is ‘Ok, I will allow alternative cigarettes if there are zero risks’. If zero risks, it means zero taste and nicotine. Nobody will buy our products,” he said.

“Sometimes, people are very emotional about cigarettes and we should stop these emotions, and have conversations about this because people around the world deserve it.”

“We will do everything we can to convince governments, like the government of Singapore. I think that as the product expands and the categories grow around the world because the benefits are clear, governments, like the government of Singapore, which is a very reasonable government in general, will also reconsider their decision.”

What happens after conversations with the government

6 artificial flavorings with cancer-causing properties – (FDA bans)

The announcement from the U.S. Food And Drug Administration carries a yawn-inducing title: “FDA Removes 7 Synthetic Flavoring Substances from Food Additives List.” It sounds like a regulatory move aimed at food-makers, and it is. But it’s one that has a slightly alarming backstory: The FDA is effectively banning these artificial substances because they have been shown to cause cancer in animals.

Under a provision of the Federal Food, Drug, and Cosmetic Act known as the Delaney Clause, the FDA cannot approve ingredients for use in food that have been found “to induce cancer in humans or animals at any dose.” Six of the substances “delisted” (effectively, banned) by the FDA have been found to cause cancer in animals exposed to very high doses. The seventh ingredient was delisted because it is no longer used at all by the food industry, the FDA says.

The six other artificial flavorings — benzophenone, ethyl acrylate, eugenyl methyl ether, myrcene, pulegone, and pyridine — are now no longer permitted for use in food, even though the FDA states that previous testing found “they do not pose a risk to public health under the conditions of their intended use.” Eager to not incite any kind of a panic, the FDA is stating the animals that developed cancer did so after exposure to very high levels of these flavorings — much higher doses than any human would likely ingest: “The FDA is only revoking the listing of these six synthetic flavorings as a matter of law. The FDA has concluded that these substances are otherwise safe.”

This latest FDA mandate comes on the heels of two other moves away from non-natural ingredients: In January, Dunkin’ announced it would phase out artificially derived coloring in its products by the end of the year, and last month, McDonald’s pledged that it would remove all artificial colorings and preservatives from its classic burgers (minus those pesky pickles). Taken together, these individual developments suggest the movement away from artificial colorings, preservatives, and flavorings is gaining serious traction.

FDA Viral news related to Health every one has to know

Fast-track review for new (e-cigs) with tech to prevent youth use-[FDA chief]

Agency’s requirement that any new e-cigarettes must undergo review before entering the market prevents them from introducing new products.

The Food and Drug Administration is considering fast-tracking the review process for e-cigarettes that include features that make the products less likely to be used by kids, Commissioner Scott Gottlieb told CNBC on Thursday.

Gottlieb last week announced a historic crackdown on e-cigarettes after reviewing unpublished federal data he’s reviewed showing teen use has reached “epidemic” levels. The FDA ordered five brands — Juul, British American Tobacco‘s Vuse, Altria’s MarkTen, Imperial Brands‘ Blu E-cigs and Japan Tobacco’s Logic — to submit plans within 60 days detailing how they will prevent teens from using their products.

Some manufacturers have said the agency’s requirement that any new e-cigarettes must undergo review before entering the market prevents them from introducing new products that could curb youth use, including bluetooth features that could disable them near schools.

Yet Gottlieb said while companies have talked about these ideas with reporters and politicians, they haven’t raised them with the FDA. He said the door is “very open to that kind of discussion.”

“I think if someone came to us with a good idea about how a product could be modified to be less appealing to kids or less prone to misuse by children, we’d be very interested in that product, and we’d be very interested in having a discussion around that and how we could put that through an efficient regulatory process,” he said.

Juul, the brand that dominates nearly 73 percent of the e-cigarette market, said it “believes technology is absolutely part of the solution.” The company plans to launch bluetooth-enabled devices internationally next year, according to a person familiar with the matter.

Products that were on the market before Aug. 8, 2016, were supposed to start undergoing review this year until Gottlieb extended the deadline until Aug. 8, 2022. He said Thursday that the FDA is actively considering reinstating the original deadline, meaning companies may soon be required to submit applications. It may also pull flavored e-cigarette products from the market until those applications are reviewed and cleared.

Critics have scolded Gottlieb for ever giving e-cigarette companies more time. He said it was necessary because it wasn’t clear what the FDA wanted from manufacturers. Now, a year later, the FDA has issued some guidelines and plans to soon release more.

If he had kept the original date, companies would have started sending in applications and wouldn’t have received a decision until next year.

“What we couldn’t anticipate, and what we didn’t anticipate, in all fairness, was how fast the youth use would accelerate,” Gottlieb said.

Finally What Fda cheif says

Dangers of Liquid Nitrogen in Food, Drinks (FDA Warns)

Inhaling the vapor released by liquid nitrogen in food or drinks can also cause breathing problems, especially among people with asthma.

Consuming or handling food and drink products where liquid nitrogen is added just before consumption can lead to serious injury, according to the U.S. Food and Drug Administration.

These products — which have names such as “Dragon’s Breath,” “Heaven’s Breath” and “nitro puff” — are available in food courts, kiosks, state or local fairs, and other places where food and drinks are sold. Examples of such products include liquid nitrogen-infused colorful cereal or cheese puffs that emit a misty or smoke-like vapor, and alcoholic and non-alcoholic drinks prepared with liquid nitrogen that emit a fog.

Liquid nitrogen isn’t toxic, but its extremely low temperature can cause severe damage to skin and internal organs if mishandled or consumed, the FDA said in a news release. Inhaling the vapor released by liquid nitrogen in food or drinks can also cause breathing problems, especially among people with asthma.


“The main issue is that liquid nitrogen must be fully evaporated from food or beverage before it is served. In liquid form, it can cause burns to the mouth, esophagus, and upper airway, leading to perforation or rupture of the organs — which could be deadly.

How it effecting to you never miss